Home » Health News » Popular weight loss drug Belviq recalled for cancer risk
Popular weight loss drug Belviq recalled for cancer risk
FidoCure helping to combat canine cancer
FidoCure CEO Christina Kelly Lopes discusses cancer in dogs and what her company is doing to tackle the issue.
The maker of a weight loss drug pulled it from the market Thursday at the request of federal regulators, who said it posed an increased risk of cancer.
Continue Reading Below
Japan’s Eisai Inc., said it was voluntarily withdrawing the drug, Belviq. However, the company said in a statement that it disagreed with the U.S. Food and Drug Administration's interpretation of new data on the drug’s safety and still believes Belviq's benefit outweighs any cancer risk.